Xinzhou Li

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Shanghai, China
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Justin Hall as attorney in fact for Xinzhou Li
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Xinzhou Li

Form 4 holding Director, 10%+ Owner

NovaBay Pharmaceuticals, Inc.

Security class
Restricted Stock Unit
Shares / value
30,000
Estimated value
$54,300
Report date
21 May 2021
Price
$1.81
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by Xinzhou Li

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .